Thus, definitions of ‘high-risk’ PCa vary, but typically involve a combined assessment of tumour stage, Gleason grade and presenting prostate-specific antigen (PSA; see Tables 1 and 2). Here, KLK3 is linked to posterior cortical atrophy.